Research at the University of Colorado found that 4:3 intermittent fasting resulted in greater weight loss than daily caloric ...

Intermittent fasting has long been a controversial weight loss technique. A new study looks at how effective it is compared ...

People taking GLP-1 drugs can decrease fat mass while minimizing muscle loss with a few key strategies that include proper ...

New research suggests the 4:3 intermittent fasting schedule is better than calorie restriction for weight loss. Previous studies found ... fasting diet. (In case you’re not familiar with it ...

Research: Body image and interest in GLP-1 weight loss medications In a recent study ... them to aid in weight reduction. Because the study sample was predominantly young, female, and college ...

Many people assume that high-intensity workouts are the only way to burn fat and lose weight. But that’s just not the case ... studies indicate that longer impulses may promote greater fat loss ...

To lose weight, Mafdali’s endocrinologist suggested GLP-1 receptor agonists: a new, enormously popular class of injectable weight-loss drugs known ... Another study has shown that Ozempic ...

Zepbound, the new GLP-1 weight-loss drug from Eli Lilly & Co., has outperformed its main competitor, Wegovy, in a clinical trial funded by Lilly.

When it comes to managing weight loss and type 2 diabetes with medications, research shows that it's out with the old and in ...

New research from CSIRO, Australia's national science agency, has busted the myth that weight loss must be a linear downward trend to be successful. The study, recently published in the Journal of ...

Popular diabetes and weight loss drugs may do more than curb appetites — they may also help reduce the risk of dementia, according to new research. Two studies that noted this unexpected effect ...